Clinical Trials Browser

Terminated × Axitinib × Other hematologic neoplasm × Clear all

NCT02782403 2020-11-19

Axitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid Leukemia

Phase 1 Terminated

Other hematologic neoplasm

Blast Crisis, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase